Real-time enrollment status for this essential thrombocythemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT04644211 |
| Recruiting Status | Recruiting |
| Condition | Essential Thrombocythemia |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | January 8, 2026 (Jan 8, 2026) |
As of March 2, 2026: Clinical trial NCT04644211 is currently recruiting participants. This clinical trial study for essential thrombocythemia is actively seeking new participants at 4 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04644211 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04644211 was last updated Jan 8, 2026 (January 8, 2026). HelloStudys verifies this status automatically.